Search filters

List of works by Gaby Sroczynski

A SYSTEMATIC REVIEW ON COST-EFFECTIVENESS STUDIES EVALUATING OVARIAN CANCER EARLY DETECTION AND PREVENTION STRATEGIES

scientific article published on 18 February 2020

Alternative Conversion Methods for Transition Probabilities in State-Transition Models: Validity and Impact on Comparative Effectiveness and Cost-Effectiveness

scientific article published on 28 June 2019

Antiviral combination therapy with interferon/peginterferon plus ribavirin for patients with chronic hepatitis C in Germany: a health technology assessment commissioned by the German Agency for Health Technology Assessment.

scientific article

Assessment of effectiveness and cost-effectiveness of HPV testing in primary screening for cervical.

scientific article

Benefits and Harms of a Prevention Program for Iodine Deficiency Disorders - Predictions of the Decision-Analytic EUthyroid Model

scientific article published on 26 August 2020

Benefits and harms of prostate cancer screening - predictions of the ONCOTYROL prostate cancer outcome and policy model

scientific article

Budget Impact Analysis of Cancer Screening: A Methodological Review

scientific article published on 01 August 2019

Clinical effectiveness and cost effectiveness of tailoring chronic hepatitis C treatment with peginterferon alpha-2b plus ribavirin to HCV genotype and early viral response: a decision analysis based on German guidelines.

scientific article published on January 2009

Cost effectiveness analysis of routine use of genotypic antiretroviral resistance testing after failure of antiretroviral treatment for HIV.

scientific article

Cost-Effectiveness of Early Detection and Prevention Strategies for Endometrial Cancer-A Systematic Review

scientific article published on 11 July 2020

Cost-effectiveness of methods in personalized medicine. Results of a decision-analytic model in patients with acute myeloid leukemia with normal karyotype

scientific article

Cost-effectiveness of primarily human papillomavirus-based cervical cancer screening in settings with currently established Pap screening: a systematic review commissioned by the German Federal Ministry of Health

scientific article published on January 2008

Cost-effectiveness of the sequential application of tyrosine kinase inhibitors for the treatment of chronic myeloid leukemia

scientific article published on 13 November 2014

Decision-analytic modeling to evaluate the long-term effectiveness and cost-effectiveness of HPV-DNA testing in primary cervical cancer screening in Germany

scientific article

Effectiveness and Cost-Effectiveness of Triple Therapy with Telaprevir and Boceprevir for Chronic Hepatitis C: A Decision Analysis from the Brazilian Public Health System Perspective

scientific article published on 17 May 2019

Effectiveness and cost-effectiveness of initial combination therapy with interferon/peginterferon plus ribavirin in patients with chronic hepatitis C in Germany: a health technology assessment commissioned by the German Federal Ministry of Health an

scientific article

Effectiveness, benefit harm and cost effectiveness of colorectal cancer screening in Austria

scientific article published on 05 December 2019

Estimation of Input Costs for a Markov Model in a German Health Economic Evaluation of Newer Antidepressants

article

Evaluating the effects of a risk-adapted screening program for familial colorectal cancer in individuals between 25 and 50 years of age: study protocol for the prospective population-based intervention study FARKOR

scientific article published on 05 May 2020

HCV-related burden of disease in Europe: a systematic assessment of incidence, prevalence, morbidity, and mortality

scientific article

Impact of increasing treatment rates on cost-effectiveness of subcutaneous immunotherapy (SCIT) in respiratory allergy: a decision analytic modelling approach

scientific article published on 24 March 2018

Long-Term Effectiveness and Cost Effectiveness of Multiple Myeloma Treatment Strategies for Elderly Transplant-Ineligible Patients in Serbia

scientific article published on 06 April 2020

Long-term effectiveness and cost-effectiveness of screening for hepatitis C virus infection.

scientific article published on 05 February 2009

Market uptake of new antiviral drugs for the treatment of hepatitis C.

scientific article published on 2 June 2008

Medical decision analysis for first-line therapy of chronic myeloid leukemia.

scientific article

Oncotyrol--Center for Personalized Cancer Medicine: Methods and Applications of Health Technology Assessment and Outcomes Research.

scientific article

Personalized treatment of women with early breast cancer: a risk-group specific cost-effectiveness analysis of adjuvant chemotherapy accounting for companion prognostic tests OncotypeDX and Adjuvant!Online.

scientific article published on 16 October 2017

Pharmacogenomics Bias - Systematic distortion of study results by genetic heterogeneity

scientific article published on 15 April 2008

Prevention of Cervical Cancer

Prevention of Cervical Cancer

scientific article published on 18 February 2019

Reducing overtreatment associated with overdiagnosis in cervical cancer screening-A model-based benefit-harm analysis for Austria

scientific article published on 24 December 2019

Systematic assessment of decision-analytic models for chronic myeloid leukemia.

scientific article published on April 2014

Systematic overview of cost-effectiveness thresholds in ten countries across four continents

scientific article published on September 2015

The German cervical cancer screening model: development and validation of a decision-analytic model for cervical cancer screening in Germany

scientific article published on 9 February 2006

The ONCOTYROL Prostate Cancer Outcome and Policy Model: Effect of Prevalence Assumptions on the Benefit-Harm Balance of Screening

scientific article published on 14 May 2015

The economic impact of prevention, monitoring and treatment strategies for iodine deficiency disorders in Germany

scientific article published on 01 December 2020

Using competence network collaboration and decision-analytic modeling to assess the cost-effectiveness of interferon alpha-2b plus ribavirin as initial treatment of chronic hepatitis C in Germany

scientific article published in June 2005

Paulina is supported by:

About Paulina

Help